Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism

Authors:

Abstract
Objective: To determine whether or not there are differences in coagulation parameters (eg, thrombelastography [TEG], activated partial thromboplastin time [aPTT], prothrombin time [PT], and fibrinogen) among dogs with naturally occurring hyperadrenocorticism (HAC), dogs withHACundergoing medical management, and dogs withoutHAC.Design: Prospective, observational study.Setting: Veterinary teaching hospital.Animals: Forty‐six client‐owned dogs undergoing adrenal function testing.Interventions: None.Measurements and Main Results: Nine dogs were diagnosed withHACde novo, 19 dogs were presented for therapeutic monitoring of previously diagnosedHAC, and 18 dogs did not haveHAC. Variables compared between groups were age, body weight, platelet count, mean platelet volume, serum concentrations of cholesterol, triglycerides, antithrombin,PT, aPTT, fibrinogen, andTEGparameters (eg, alpha angle,R,K, and maximum amplitude [MA]). Dogs withHACand dogs treated forHAChad higher serum cholesterol than dogs withoutHAC(P< 0.05). All groups had meanMAgreater than the institutional reference interval. There was a weak, positive correlation between hematocrit andMAthat was independent of diagnosis (r2= 0.266,P= 0.004).Conclusions: The results of this study do not support the supposition that a significant difference exists in coagulation tendencies between dogs withHACprior to treatment, dogs withHACduring treatment, and dogs withoutHAC. This disagreement with the classically accepted notion thatHACleads to a hypercoagulable state could be due to a couple of possibilities. Namely, the link betweenHACand hypercoagulability may be relatively weak, or our findings may be the result of a typeIIerror either as a result of a small sample size or the use of coagulation assays that are insensitive to the effects ofHACon the hemostatic system.

This publication has 31 references indexed in Scilit: